Articles by admin
Genotype-to-Drug Associations
Genotype-to-drug associations play a vital role in personalized medicine, enabling healthcare providers to tailor treatments based on an individual’s genetic makeup. In this section, you can explore the relationships between specific genetic variants and their […]
Drug-to-Genotype Associations (FDA List)
The FDA recognizes the importance of understanding drug-to-genotype associations in order to optimize treatment and minimize adverse effects. In this section, you can access a comprehensive list of FDA-recognized associations, which can provide valuable insights […]
Drug-to-Genotype Associations (All)
A deeper understanding of the interactions between genetics and drug response is critical for advancing personalized medicine. In this section, you can explore our extensive database of drug-to-genotype associations, including those not recognized by the […]
Tumor Mutation Load Assay
At Genet, we offer the “Oncomine Tumor Mutation Load Assay,” a cutting-edge service designed to identify cancer driver variants and evaluate tumor mutational burden (TMB), a promising immuno-oncology biomarker, utilizing next-generation sequencing technology. Immune checkpoint […]
Solid Tumor
An abnormal mass of tissue that usually does not contain cysts or liquid areas. […]
Myeloid disorders
Myeloid disorders comprise a diverse group of hematologic conditions, including various forms of leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. At Genet, we are committed to advancing clinical research in the field of myeloid disorder genetics. […]
Liver Cancer
Liver Cancer Research Liver cancer is a malignant condition that originates in the liver cells, with hepatocellular carcinoma being the most common form. At Genet, we are dedicated to advancing clinical research in the field […]
HRR Pathway
The following targets are included in the Oncomine™ HRR Pathway Predesigned Panel: